Fig. 4From: Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their developmentAbsolute change in left ventricular ejection fraction from baseline in the seven patients with available echocardiograms as baseline and after pazopanib initiation. LVEF: left ventricular ejection fractionBack to article page